Log In
Print
BCIQ
Print
Print this Print this
 

esketamine (AM-101)

  Manage Alerts
Collapse Summary General Information
Company Auris Medical Holding AG
DescriptionIntratympanicly injected non-competitive antagonist of NMDA receptors
Molecular Target NMDA receptor
Mechanism of ActionNMDA receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationTinnitus
Indication DetailsTreat acute peripheral (inner ear) tinnitus
Regulatory Designation

U.S. - Special Protocol Assessment (Treat acute peripheral (inner ear) tinnitus)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today